NCT04025853View on ClinicalTrials.gov

Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis

CompletedOBSERVATIONAL
Enrollment

455

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Diabetic Foot Ulcer
Trial Locations (1)

75390

UT Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT04025853 - Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis | Biotech Hunter | Biotech Hunter